Submission of Matters to a Vote of Security Holders.
On October 19, 2016, BioRestorative Therapies, Inc. (the " Company ") held its Annual Meeting of Stockholders (the " Annual Meeting "). The following is a listing of the votes cast for or withheld, and the number of broker non-votes, with respect to the nominees for Class II director and a listing of the votes cast for and against, as well as abstentions and broker-non votes, with respect to each other matter voted upon at the Annual Meeting, as applicable. At the Annual Meeting, the Company's stockholders (i) elected the nominees as Class II director, (ii) approved the Company's executive compensation, (iii) approved an amendment to the Company's 2010 Equity Participation Plan (the " Plan ") to increase the number of shares of common stock authorized to be issued pursuant to the Plan from 2,250,000 to 4,250,000, and (iv) ratified the selection of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2016.
1.
Election of Class II Directors:
Number of Shares
For
Withheld
Broker Non-Votes
John M. Desmarais
1,902,887
526
539,350
Paul Jude Tonna
1,902,811
602
539,350
2.
Approval of the Company's executive compensation:
For
1,878,555
Against
3,325
Abstentions
21,533
Broker Non-Votes
539,350
3.
Approval of an amendment to the Company's 2010 Equity Participation Plan to increase the number of shares of common stock authorized to be issued pursuant to the plan from 2,250,000 to 4,250,000:
For
1,879,857
Against
23,547
Abstentions
9
Broker Non-Votes
539,350
4.
Ratification of the selection of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2016:
For
2,442,759
Against
0
Abstentions
4
